vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $30.9M, roughly 1.9× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -12.5%, a 59.2% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 5.6%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $16.1M). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs -0.0%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

CBAT vs CHCT — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.9× larger
CBAT
$58.8M
$30.9M
CHCT
Growing faster (revenue YoY)
CBAT
CBAT
+126.1% gap
CBAT
131.8%
5.6%
CHCT
Higher net margin
CHCT
CHCT
59.2% more per $
CHCT
46.6%
-12.5%
CBAT
More free cash flow
CHCT
CHCT
$19.8M more FCF
CHCT
$35.9M
$16.1M
CBAT
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
-0.0%
CBAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
CHCT
CHCT
Revenue
$58.8M
$30.9M
Net Profit
$-7.4M
$14.4M
Gross Margin
7.3%
Operating Margin
-13.6%
Net Margin
-12.5%
46.6%
Revenue YoY
131.8%
5.6%
Net Profit YoY
-63.6%
687.6%
EPS (diluted)
$-0.08
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
CHCT
CHCT
Q4 25
$58.8M
$30.9M
Q3 25
$60.9M
$31.1M
Q2 25
$40.5M
$29.1M
Q1 25
$34.9M
$30.1M
Q4 24
$25.4M
$29.3M
Q3 24
$44.6M
$29.6M
Q2 24
$47.8M
$27.5M
Q1 24
$58.8M
$29.3M
Net Profit
CBAT
CBAT
CHCT
CHCT
Q4 25
$-7.4M
$14.4M
Q3 25
$2.7M
$1.6M
Q2 25
$-3.1M
$-12.6M
Q1 25
$-1.6M
$1.6M
Q4 24
$-4.5M
$1.8M
Q3 24
$17.6K
$1.7M
Q2 24
$6.4M
$-10.4M
Q1 24
$9.8M
$3.7M
Gross Margin
CBAT
CBAT
CHCT
CHCT
Q4 25
7.3%
Q3 25
8.0%
Q2 25
11.0%
Q1 25
13.7%
Q4 24
13.1%
Q3 24
15.6%
Q2 24
26.6%
Q1 24
31.9%
Operating Margin
CBAT
CBAT
CHCT
CHCT
Q4 25
-13.6%
Q3 25
-6.6%
Q2 25
-8.7%
Q1 25
-8.2%
Q4 24
-26.0%
Q3 24
-1.9%
Q2 24
12.4%
Q1 24
17.4%
Net Margin
CBAT
CBAT
CHCT
CHCT
Q4 25
-12.5%
46.6%
Q3 25
4.4%
5.3%
Q2 25
-7.6%
-43.2%
Q1 25
-4.5%
5.3%
Q4 24
-17.8%
6.3%
Q3 24
0.0%
5.9%
Q2 24
13.5%
-37.9%
Q1 24
16.7%
12.5%
EPS (diluted)
CBAT
CBAT
CHCT
CHCT
Q4 25
$-0.08
$0.52
Q3 25
$0.03
$0.03
Q2 25
$-0.03
$-0.50
Q1 25
$-0.02
$0.03
Q4 24
$-0.05
$0.04
Q3 24
$0.00
$0.04
Q2 24
$0.07
$-0.42
Q1 24
$0.11
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$8.3M
$3.3M
Total DebtLower is stronger
$4.1M
$532.2M
Stockholders' EquityBook value
$112.7M
$429.4M
Total Assets
$426.2M
$990.8M
Debt / EquityLower = less leverage
0.04×
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
CHCT
CHCT
Q4 25
$8.3M
$3.3M
Q3 25
$10.5M
$3.4M
Q2 25
$45.7M
$4.9M
Q1 25
$9.6M
$2.3M
Q4 24
$11.0M
$4.4M
Q3 24
$24.2M
$2.8M
Q2 24
$44.1M
$734.0K
Q1 24
$23.8M
$3.8M
Total Debt
CBAT
CBAT
CHCT
CHCT
Q4 25
$4.1M
$532.2M
Q3 25
$4.8M
$530.1M
Q2 25
$4.9M
$500.1M
Q1 25
$4.1M
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CBAT
CBAT
CHCT
CHCT
Q4 25
$112.7M
$429.4M
Q3 25
$121.4M
$426.8M
Q2 25
$118.2M
$437.8M
Q1 25
$120.8M
$461.3M
Q4 24
$121.7M
$476.0M
Q3 24
$131.2M
$477.2M
Q2 24
$126.6M
$497.8M
Q1 24
$120.9M
$511.6M
Total Assets
CBAT
CBAT
CHCT
CHCT
Q4 25
$426.2M
$990.8M
Q3 25
$363.9M
$987.3M
Q2 25
$333.1M
$966.3M
Q1 25
$311.5M
$985.1M
Q4 24
$302.2M
$992.6M
Q3 24
$293.5M
$981.8M
Q2 24
$279.6M
$983.2M
Q1 24
$286.5M
$982.7M
Debt / Equity
CBAT
CBAT
CHCT
CHCT
Q4 25
0.04×
1.24×
Q3 25
0.04×
1.24×
Q2 25
0.04×
1.14×
Q1 25
0.03×
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
CHCT
CHCT
Operating Cash FlowLast quarter
$29.8M
$56.4M
Free Cash FlowOCF − Capex
$16.1M
$35.9M
FCF MarginFCF / Revenue
27.3%
116.0%
Capex IntensityCapex / Revenue
23.4%
66.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
CHCT
CHCT
Q4 25
$29.8M
$56.4M
Q3 25
$14.6M
$12.7M
Q2 25
$13.8M
$13.8M
Q1 25
$-9.6M
$14.4M
Q4 24
$9.6M
$58.9M
Q3 24
$19.7M
$13.8M
Q2 24
$2.9M
$16.7M
Q1 24
$7.4M
$12.6M
Free Cash Flow
CBAT
CBAT
CHCT
CHCT
Q4 25
$16.1M
$35.9M
Q3 25
$6.0M
$7.6M
Q2 25
$4.1M
$9.6M
Q1 25
$-22.3M
$9.7M
Q4 24
$3.9M
$34.2M
Q3 24
$16.5M
$6.7M
Q2 24
$2.5M
$9.5M
Q1 24
$-454.0K
$7.5M
FCF Margin
CBAT
CBAT
CHCT
CHCT
Q4 25
27.3%
116.0%
Q3 25
9.9%
24.6%
Q2 25
10.2%
32.9%
Q1 25
-63.9%
32.3%
Q4 24
15.5%
116.9%
Q3 24
37.1%
22.5%
Q2 24
5.2%
34.7%
Q1 24
-0.8%
25.7%
Capex Intensity
CBAT
CBAT
CHCT
CHCT
Q4 25
23.4%
66.3%
Q3 25
14.1%
16.3%
Q2 25
23.8%
14.5%
Q1 25
36.3%
15.6%
Q4 24
22.5%
84.1%
Q3 24
7.0%
24.2%
Q2 24
0.9%
26.1%
Q1 24
13.4%
17.4%
Cash Conversion
CBAT
CBAT
CHCT
CHCT
Q4 25
3.91×
Q3 25
5.51×
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
1115.72×
7.92×
Q2 24
0.46×
Q1 24
0.76×
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

CHCT
CHCT

Segment breakdown not available.

Related Comparisons